Internal Medicine · 1998 · 21 citations · 21 references
Life SciencesCancer BiologyCell BiologyApoptosisCell ProliferationMolecular OncologyApoptosis In CancerApoptosis RegulationApoptosis ResistanceApoptotic Signal TransductionApoptotic SignalingCell DeathApoptosis Resistance In TumorsApoptotic Signaling In CancerHepatic ApoptosisLiver Cell Death PathwaysPro-apoptotic ProteinsSurvival FactorSurvival Factor Signaling
not observed for the mature form, and that proHB-EGFmay act as a tumor survival factor in hepatoma cells. Hepatomasat the earliest stage do not always need rapid growth, but it is necessary for escape from various immune systems. Resistance against several factors may play a role in the early progression of hepatomas. A hepatoma overexposing proHB-EGFshowed strong resistance to several factors. Although the mechanismunderlying resistance to TGFp-induced apoptosis remain unknown, the resistance to serum-starved treatment is thought to be due to Gl arrest induced by upregulation ofp21. In somecases, cells under Gl arrest undergo apoptosis. However, PHB-AHcells showed slow growth with a high percentage of the Gl phase in the cell cycle. Thus, proHB-EGFspecifically may act as a cell survival factor in liver tissues.
21
Mitochondrial Complex I Deficiency in Parkinson's Disease
Anthony H.V. Schapira, Jonathan M. Cooper, David T. Dexter et al. · Journal of Neurochemistry · 1990 · 2.3K citations
Bettina Grasl Kraupp, Branislav Ruttkay-Nedecký, Helga Koudelka et al. · Hepatology · 1995 · 1.2K citations · Full text
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Philippe Anglade, Sheela Vyas, F. Javoy‐Agid et al. · PubMed · 1997 · 1K citations · Full text